New partnership brings Creo’s CROMA-powered GI devices to Scandinavia
Clinicians in Denmark, Sweden and Norway will soon gain access to Creo Medical’s advanced endoscopic energy technology, following a new distribution partnership with Ferdinand Medical.
Expanding access to advanced endoscopic energy
Three of Creo Medical’s devices – Speedboat™ UltraSlim, Speedboat™ Notch and Spydrblade™ Flex – powered by the CROMA Advanced Energy Platform, will be available to healthcare professionals in Denmark, Sweden and Norway for use in advanced therapeutic endoscopy. These devices combine precise cutting with bipolar RF energy and coagulation with microwave energy to support minimally invasive treatment of complex lesions in the Gastrointestinal tract.
A partner with deep MIS experience
For Ferdinand Medical, the partnership builds on a long history in minimally invasive surgery.
Ferdinand Medical CEO Kent Ferdinand said:
“Ferdinand Medical has many years of experience working with advanced energy in minimally invasive surgery (MIS). However, this is the first time we have encountered an energy platform and concept as impressive as Creo Medical’s for procedures such as ESD, POEM, and Zenker’s diverticulotomy… We look forward to supporting physicians with this groundbreaking technology and to strengthening advanced endoscopic and minimally invasive procedures across Scandinavia.”
His comments underline the potential of the CROMA Advanced Energy Platform to support procedures such as ESD, POEM and Zenker’s diverticulotomy in routine clinical practice.
Supporting better outcomes across Scandinavia
Creo Head of Sales and Service Operations Richard Lawrence, who facilitated the partnership, said
“We’re excited to be working with the fantastic team at Ferdinand Medical. Their expertise in the sector and commitment to supporting clinicians has been clear throughout this process. Together, we look forward to introducing our technology into hospitals across the region and helping teams deliver precise, minimally invasive treatment options that can improve patient outcomes and streamline care pathways.”
By combining Creo’s advanced energy platform with Ferdinand Medical’s established presence in Scandinavia, the partnership aims to:
- expand access to minimally invasive endoscopic therapies
- reduce reliance on major surgery for complex GI cases
- support shorter recovery times and more efficient patient pathways
Clinicians interested in bringing advanced endoscopic energy into their department can learn more by browsing our Advanced Energy range.
Posted 16/01/2026
For press enquiries please contact media@creomedical.com. For all other enquiries please visit our Contact page.
